International Diabetes Federation | IDF
IDF 2011 | Dubai
Show data as:
List view
Grid view
Date:
Monday
Tuesday
Wednesday
Thursday
Stream:
Clinical and Basic Science
Education and Integrated Care
Global Challenges in Health
Health Systems and Epidemiology
Living with diabetes
Session Format:
Debate
Late-Breaking Abstract
Meet-the-Expert
Named Lecture
Open Forum
Oral Presentation
Poster Discussion
Poster Display
Presidential Oration
Satellite Symposium
Speakers' Corner
Symposium
Teaching Lecture
Workshop
Topic:
21st century vision for an integrated system to control and prevent diabetes
A new class of drugs: Inhibitors of renal glucose transport
Acting on a larger stage 1: Advocacy and reform in a post-UN-Summit world
Acting on a larger stage 2: Learning from and working with AIDS, Cancer, CVD, TB
Adipocyte biology: Basic science translated to the clinician
Advocacy and reform in a post UN Summit world
Age and gender in diabetes
Alternative medicine
Alternative medicine in animals of type 2 diabetes
An effective obesity program for diabetes: What are the key components?
An integrated NCD programme: The Health Authority of Abu Dhabi
Approaches to the treatment of obesity: Why and what?
Are young diabetic patients more at risk than late onset patients in developing countries?
Assessing and treating gestational diabetes
Association development
Basic aspects of vascular complications
Basic science of incretins for the clinician
Bayer
Behind the new estimates: How IDF now calculates diabetes prevalence by country and region
Biological mismatching and modernisation: Unravelling multi-causality
Blood pressure
Blood pressure should be lowered as much as possible in people with type 2 diabetes
Boehringer Ingelheim
Brain control (or lack of) in diabetes and obesity
Bridges
Burden of diabetes and its comorbidities
C-Reactive protein is critical for identifying CVD risk!
Cardiovascular complications of diabetes in cell and animal models
Cardiovascular complications of diabetes in humans
Cardiovascular risk and diabetes medications: The ups and downs
Care for the hospitalised patient
Cellular and physiological mechanisms of insulin resistance
Central connections
Centres of Education
Challenges of insulin therapy in developing societies
Challenges, opportunities and successes around the world
Clinical care guidelines
Clinical outcomes with incretins
Complications in the eye
Complications in the feet
Cost and cost-effectiveness
Cost and cost-effectiveness
Creating access to affordable medicines and cost-effective technologies
Creative approaches to diabetes education
D-Net: A new forum for diabetes educators
Delivery of diabetes care
Designing effective national surveillance systems for diabetes and other NCDs (Part 1)
Designing effective national surveillance systems for diabetes and other NCDs (Part 2)
Detection and prevention of diabetes and its complications
Development of the adolescent diabetes needs assessment tool (ADNAT)
Diabetes and children
Diabetes and co-morbidities
Diabetes and complications
Diabetes and driving
Diabetes and exercise
Diabetes and indigenous people
Diabetes and infections
Diabetes and insulin
Diabetes and natural disasters
Diabetes and technology
Diabetes and travelling
Diabetes associations support
Diabetes camps: Retreats for children and young people with diabetes
Diabetes care across lifespan: What's the evidence? What works?
Diabetes care in the real world
Diabetes day by day
Diabetes education across the ages
Diabetes education and technology
Diabetes education delivery
Diabetes education delivery
Diabetes education from around the world
Diabetes education: A melting pot of creativity
Diabetes education: The essence of care
Diabetes from birth to youth
Diabetes in China
Diabetes in developing and non-white populations
Diabetes in pregnancy: From epidemiology to therapy
Diabetes in rural areas
Diabetes in special and ageing populations
Diabetes is harder to treat in the Middle East: The role of Arab culture
Diabetes knowledge and feelings
Diabetes prevalence
Diabetes quality of care
Diabetes, comorbidities and psychological health
Diabetes/NCDs and economic development
Diabetes: Beyond cardiovascular complications
Diabetes: The expert patient
Diabetic complications: What does the educator need to know?
Diabetic renal disease and its treatment
Diagnosis and prediction of diabetes and prediabetes
Dialogue on diabetes and depression
Disease burden, care delivery and quality assurance
Does the pathophysiology of type 2 diabetes differ between races and between countries?
Drawing up national guidelines for diabetes management: The role of the national diabetes associations
Dubai Dialogue
Early intervention to prevent diabetes must include medication
Economic analysis methods and concepts
Economic simulation modelling for clinical care and policy
Ectopic fat and diabetes: Fat by chance
Educating the health professional
Education strategies to get the most out of today's diabetes technology
Effective delivery of diabetes education
Emerging risk factor for diabetes
Engaging people at the community level through innovative participatory media and learning strategies
Engaging the person in their dabetes self-care
Engaging the person in their healthcare: How do we help the person who doesn't seem interested?
Engaging the person with diabetes in self-management
Engaging the person with diabetes in self-management
Epidemiology for policy development
Epidemiology of diabetes, obesity and more
Ethnicity, acculturation and lifestyle in diabetes
Evening with the president
Exercising for glucose
Facilitating the adoption and implementation of diabetes prevention and control resources in organisations serving ethnic minority populations
Fixing feet
Fueling type 2 diabetes
Fundraising and sustainability for diabetes associations
GDM: IDF model approach
General management of diabetic nephropathy
Genetic information improves prediction, prevention and control of type 2 diabetes
Genetic insights into risk factors and complications of diabetes
Genetics of type 2 diabetes: What's new?
Getting to the heart of the matter in diabetic cardiovascular disease
Getting your article published: What do the journals look for?
Glucose lowering: from gut to kidney
Glucose variability and diabetic complications: Should we care?
Glycated haemoglobin: Where does it fit?
Going beyond current standards of care in patients with type 2 Diabetes
HbA1c for diagnosis: Progress or the wrong direction?
HbA1c, SMBG or both?
Health in all policies: Climate change, food policy and urban design
Holding back insulin resistance in the metabolic syndrome
How do you take a diet history and give nutrition advice when you don't have a dietician?
How does the non-psychologist team member identify and deal with diabetes-related distress
How to use new media and Web 3.0 for advocacy
Hypoglycaemia: Causes and outcomes
Identifying regional issues with education and shifting the paradigm to cope
IDF Award Lecture Basic Science
IDF Award Lecture Clinical Science
IDF Award Lecture Education and Integrated Care
IDF Award Lecture Health Systems and Epidemiology
IDF Award Lecture Life with Diabetes
IDF education activities: Centres of Education
IDF Global Risk Assessment Program
Impact of diabetes on quality of life
Improving Health Outcomes in 2011 for patients with Type 2 Diabetes
Improving the Diabetes Injection Experience through Science and Innovation
Incretin based therapy: Now and down the road
Inflammation and infection
Innovative approaches to the delivery of diabetes education
Innovative tools for diabetes education
Ins and outs of incretin therapies
Insulin resistance in young and old
Insulin secretion in vitro and in vivo
Insulin therapy in type 2 diabetes: Who, when and how
Insulin therapy: From monitoring to control
Insulin treatment: Glucose and other outcomes
Integrating diabetes care for those with mental illness
Internists and pediactrians working together to improve the care of children and adolescents with diabetes in developing countries
Is bariatric surgery an appropriate treatment for the majority of type 2 diabetic patients?
Islet transplantation: Bench to bedside
ISPAD lecture
It is time to perform screening for diabetes and high risk conditions
Keeping watch over circulating glucose
Key data for policy development
Late-breaking abstracts session
Late-breaking clinical trials
Late-breaking: Cardiovascular complications
Late-breaking: Genetics
Late-breaking: Novel mechanisms and treatments
Learning from monogenic diabetes
Life for a Child Program
Lipids and atherosclerosis
Living with diabetes and depression
Living with diabetes and quality of life
Living with the complications of type 1 diabetes
Living with the complications of type 2 diabetes
Low carbohydrate diets are the answer to improved glycaemic control
Management of hyperglycaemia in critical care and other in-patient settings
Management strategies for ensuring successful athletic performance
Managing pregnancy in pre-existing diabetes
Marking, bypassing and treating obesity
Measurements of biomarkers of diabetic complications
Measuring renal function in diabetes
Metabolic insulin resistance
Metabolic memory: A legacy effect
Modelling diabetes and obesity through animals
More challenges, opportunities and programs
More successful programs for difficult settings
Mortality and complications in diabetes
My life after islet transplant
National and population-wide programs for diabetes prevention and care
Natural and non-traditional approaches to treating diabetes
Nerves in diabetes
Networking in diabetes
Neural complications of diabetes
New and old targets for diabetic complications
New avenues for prevention of ß-cell loss in type 1 diabetes
New criteria for the diagnosis and classification of hyperglycaemia in pregnancy
New looks at ß-cell function and survival
New news on combination therapies of type 2 diabetes
Novel basic science of diabetic complications
Nutrition and diabetes
Obesity in Arab countries
Oral health in people with diabetes
Pathogenesis of type 2 diabetes: Which is the predominant culprit?
Patients perspectives: Women living with diabetes
Pay for performance improves diabetes control
Payment for diabetes care and prevention: Lessons from different models
Peer-to-peer education
Personalised care versus evidence based medicine
Polypill for cardiovascular and renal protection: Where do we stand?
Poster Presentation: Clinical and Basic Science
Poster Presentation: Education and Integrated Care
Poster Presentation: Global Challenges in Health
Poster Presentation: Health Systems and Epidemiology
Poster Presentation: Life with Diabetes
Prediction for diabetes and its complications
Prevention of diabetic foot: An Asia-Pacific initiative
Primary and secondary prevention of diabetes and its complications
Primary versus secondary prevention: What should be the first priority?
Producing research that is useful world wide
Progress against diabetes in the Gulf States
Psychosocial and behavioral interventions
Ramadan: Fasting with diabetes
Replacing ß-cells from alternative sources
Reporting on Bridges projects
Role of the newer drugs for diabetes in developing countries
Sadly discrimination affects the life of people with diabetes
Should IDF accept commercial funding?
Sleep, psychological health and cultural needs in diabetes
Social and economic impact of diabetes: New data
Special challenges in diabetes
State-of-the-(HE)ART-symposium: CVD risk prediction and management
Stressing out the ß-cell
Successfull programs for low-resourced settings
Surveillance and primary prevention in real practice
Tackling type 1 diabetes today
The 'step by step': Improving diabetic foot care in the developing world programme, is it successful?
The artificial pancreas
The brain in diabetes
The culprits for the current diabetes epidemic
The endothelium in diabetes
The evolution of DPP-4 Inhibition in Type 2 Diabetes
The evolving role of the diabetes health professional
The impact of diabetes
The importance of oral health in diabetes management : the role of the diabetes care provider
The leading ß-cell partner in type 2 diabetes: It is mass, not function!
The science around peer education
Traditional and emerging risk factors for diabetes
Traditional, novel and emerging risk factors in diabetes and prediabetes
Transforming clinical practice through epidemiology
Treating diabetes under challenging circumstances
Treatment of type 2 diabetes: a matter of proof
Turning the tide of diabetes together
Type 1 diabetes: A disease of all ages implying different strategic approaches
Type 2 diabetes and the liver
Type 2 diabetes genes
Type 2 diabetes in children
Type 2 diabetes: Genes and screens
UNESCO H.Mehnert Lecture
Using art in person-centred therapies
Utilising technology for better clincial outcomes in young people
Utilising technology to enhance education
What are the critical issues and culturally specific solutions for nutrition in your country or region?
What can we learn from diabetes epidemiology in developing regions?
What did we learn from the recent megatrials?
What should follow metformin?
What should the clinician know about statistics in clinical trials?
Will the commitments made at the UN Summit translate from the global to the local?
Will the commitments made at the UN Summit translate from the global to the local
Women's role in diabetes and NCD prevention
You are what you eat: Nutrition in diabetes and obesity
Young leaders in diabetes
Keyword:
Author name:
Skip to content
Skip to menu
Home
Contact
Subscribe to newsfeed
Sitemap